One of the study's leaders at the University of Cambridge stresses the ability of an MS drug to promote brain repair is unprecedented.
The drug is also know by it's lab name as alemtuzumab. In the three year study, it appeared to reduce fatigue and physical impairment. Some patients even recovered lost functions.
MS support groups are giving the finding a warm welcome but caution that more research is needed.
